MedTrace Logo

Food-Effect Pharmacokinetic Study of PL2200

NCT01244100 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2010-12-13

No results posted yet for this study

Summary

This trial is a food-effect study to assess fasted versus fed pharmacokinetics of PL2200.

Conditions

  • Healthy

Interventions

DRUG

PL2200 fasted

Fasted state

DRUG

PL2200 fed

Fed state

Sponsors & Collaborators

  • PLx Pharma

    lead INDUSTRY

Principal Investigators

  • Upendra K Marathi, PhD · PLx Pharma Inc.

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2010-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01244100 on ClinicalTrials.gov